Stay updated on Cabozantinib for Adrenocortical Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib for Adrenocortical Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib for Adrenocortical Carcinoma Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    Deployment of revision v3.5.0 replacing v3.4.3. No visible user-facing content changes were observed.
    Difference
    0.1%
    Check dated 2026-03-21T18:58:46.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    A new revision note is added: Revision: v3.4.3, replacing Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-07T09:58:25.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed Revision: v3.4.1.
    Difference
    0.1%
    Check dated 2026-02-13T17:11:08.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    Revision: v3.4.1 replaces v3.4.0. This appears to be a minor site maintenance update with no changes to study content or user interactions.
    Difference
    0.1%
    Check dated 2026-02-06T11:32:01.000Z thumbnail image
  8. Check
    61 days ago
    Change Detected
    Summary
    The page shows a minor system revision update from v3.4.0 to v3.4.1; there are no changes to core content, trial details, or user-facing features. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-05T12:43:16.000Z thumbnail image
  9. Check
    82 days ago
    Change Detected
    Summary
    New revision label 'Revision: v3.3.4' appears, replacing the previous 'Revision: v3.3.3'. This is a minor update that does not affect the study details or outcomes.
    Difference
    0.1%
    Check dated 2026-01-15T03:10:02.000Z thumbnail image

Stay in the know with updates to Cabozantinib for Adrenocortical Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib for Adrenocortical Carcinoma Clinical Trial page.